Idrx
IDRx is a clinical-stage biopharmaceutical company based in Plymouth, Massachusetts, focused on revolutionizing cancer treatment through precision combination therapies. Founded in 2022, IDRx aims to enhance patient outcomes with intelligently designed solutions tailored to target cancer more effectively.
National Ranking
17769th
in United StatesRegional Ranking
19395th
in North AmericaGlobal Ranking
49520th
worldwideRankings by 